SCHEMBL6879696

SCHEMBL6879696

CC(Oc1ccccc1)C(=O)NC1CCC(Nc2nccc(N(C)C)n2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.47
MCHR1 Q99705 6/20 0.44
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
HPGD P15428 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
CNR1 P21554 1/20 0.41
KCNH2 Q12809 1/20 0.41
AURKB Q96GD4 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
MAPK1 P28482 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALPL P05186 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAPK8 P45983 2/20 0.40
CYP2C9 P11712 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6879679 1.00 TSHR (0.47) TSHRMCHR1MAPTHTTHPGD
SCHEMBL6878921 0.88 MCHR1 (0.42) MCHR1ADORA3ADORA2AADORA1SMN1; SMN2
SCHEMBL6878928 0.88 MCHR1 (0.42) MCHR1ADORA3ADORA2AADORA1SMN1; SMN2
SCHEMBL6460241 0.87 ALDH1A1 (0.46) TSHRMCHR1HTTADORA3ADORA2A
SCHEMBL6460258 0.87 ALDH1A1 (0.46) TSHRMCHR1HTTADORA3ADORA2A
SCHEMBL6457914 0.83 CCR1 (0.43) MCHR1MAPK8CYP2C9CCNE1CDK2
SCHEMBL6457922 0.83 CCR1 (0.43) MCHR1MAPK8CYP2C9CCNE1CDK2
SCHEMBL6867727 0.82 TSHR (0.43) TSHRMCHR1HPGDCNR1KCNH2
SCHEMBL6455514 0.82 LMNA (0.50) MCHR1HTTHPGDSMN1; SMN2MAPK1
SCHEMBL6455521 0.82 LMNA (0.50) MCHR1HTTHPGDSMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed